T.TST
|
Any thoughts why they did not include - "35% Year 1 DFS rate in patients...
|
T.TST
|
Interesting story and not unlike Telesta/MCNA. - Albeit Auspex with seemingly...
|
T.TST
|
and nobody is quite sure when it will hit the top"*. --- One word to...
|
T.TST
|
I did not see anything about Telesta from Doug Loe . But an interesting...
|
T.TST
|
"The Life Sciences Report", From Streetwise, is emailed every...
|
T.TST
|
Douglas Loe, healthcare equity analyst with Euro Pacific Canada, brings more...
|
T.TST
|
Bloomberg 3 hours ago - Euro Pacific Canada analyst, Douglas Loe Mr. newly...
|
T.TST
|
Beech, the post announcement part of the Endocyte / Merck story (re licensing...
|
T.TST
|
If I understand correctly, Telesta has been working closely with the FDA re...
|
T.TST
|
http://finance.yahoo.com/news/telesta-therapeutics-publishes-6-month...
|
T.TST
|
TORONTO, Feb. 13, 2015 /CNW/ - The following issues have been halted by IIROC...
|
T.TST
|
Telesta Therapeutics to resume at 7 a.m. PT 2015-02-13 09:26 ET - Resume...
|
T.TST
|
2015-02-13 09:22 ET - H Telesta Therapeutics Inc. has been halted at 6:19 a.m...
|
T.TST
|
fyi....Mitomycin or mitomycin-C (Mutamycin, Mfr.: Bristol-Myers Squibb) used...
|
T.TST
|
If Sujan Lahiri (Seeking Alpha) provides an opinion after reviewing Telesta...
|
T.TST
|
Could have 2 additional little tabs, maybe in lower part of the huge "...
|
T.TST
|
Liked seeing the latest "Corporate presentation" cover shown right...
|
T.TST
|
A terrific example of what good/any PR can accomplish. Title of article...
|
T.TST
|
It was interesting seeing how many biotechs, with market caps under $100...
|
T.TST
|
Timely to switch communication strategy/goal from being "Canada's...
|